WeylChem Acquires Catexel Businesses

WeylChem Acquires Catexel Businesses
WeylChem Acquires Catexel Businesses

International Chemical Investors Group (ICIG) and WeylChem Group together have acquired the Home Care, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures.

With the buy WeylChem said it is broadening its portfolio of performance chemicals, thus gaining access to additional markets in industrial & institutional cleaning, textile bleaching, pulp bleaching and process technologies. The buy strengthens its leading position as supplier and manufacturer of oxidation catalysts and bleach activators, it added.

The transaction, which comprises the intellectual property of Catexel for a variety of applications, aso increases the innovation capabilities of the combined businesses through its dedicated R&D team, the German group said.

Andreas Maier, managing director of WeylChem Performance Products and head of the Consumer Care business unit, said the combination of its own and Catexel’s capabilities “creates a leading global expert in the field of oxidation catalysis.”

For ICIG, managing director Achim Riemann commented that the purchase fits well with its strategy to enhance its platforms by supporting add-on acquisitions.

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read